Cambridge researchers developing new therapies as part of a collaborative programme with industry.
Can better decisions be made about which anticancer drugs to progress to clinical trials?
GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity...
